Select Medical Holdings Corp. Files Q2 2024 10-Q
Ticker: SEM · Form: 10-Q · Filed: Aug 1, 2024 · CIK: 1320414
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: SEM
TL;DR
**SELECT MEDICAL HOLDINGS CORP (SEM) files Q2 10-Q. Financials and operations update.**
AI Summary
Select Medical Holdings Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing operations in the healthcare services sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational performance of Select Medical Holdings Corp., crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the healthcare sector can be subject to regulatory and reimbursement risks not detailed in this summary.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORP (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 20240801 (date) — Filing date
- 0001320414 (company) — Central Index Key for Select Medical Holdings Corp.
FAQ
What were Select Medical Holdings Corp.'s total revenues for the six months ended June 30, 2024?
The filing indicates financial data for the six months ended June 30, 2024, but specific revenue figures are not provided in this header information.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the SEC file number for Select Medical Holdings Corp.?
The SEC file number is 001-34465.
When was this 10-Q form filed?
This 10-Q form was filed on August 1, 2024.
What is the primary business of Select Medical Holdings Corp. according to the SIC code?
The Standard Industrial Classification (SIC) code is 8060, indicating the company operates in the Hospitals sector.
Filing Stats: 4,588 words · 18 min read · ~15 pages · Grade level 18.8 · Accepted 2024-08-01 16:32:18
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
Filing Documents
- sem-20240630.htm (10-Q) — 1870KB
- sem-630202410qxex311.htm (EX-31.1) — 12KB
- sem-630202410qxex312.htm (EX-31.2) — 12KB
- sem-630202410qxex321.htm (EX-32.1) — 7KB
- 0001628280-24-034182.txt ( ) — 8374KB
- sem-20240630.xsd (EX-101.SCH) — 40KB
- sem-20240630_cal.xml (EX-101.CAL) — 89KB
- sem-20240630_def.xml (EX-101.DEF) — 175KB
- sem-20240630_lab.xml (EX-101.LAB) — 550KB
- sem-20240630_pre.xml (EX-101.PRE) — 395KB
- sem-20240630_htm.xml (XML) — 1558KB
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 23 ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 42 ITEM 4.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 42 PART II OTHER INFORMATION 43 ITEM 1.
LEGAL PROCEEDINGS
LEGAL PROCEEDINGS 43 ITEM 1A.
RISK FACTORS
RISK FACTORS 43 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 43 ITEM 3. DEFAULTS UPON SENIOR SECURITIES 43 ITEM 4. MINE SAFETY DISCLOSURES 43 ITEM 5. OTHER INFORMATION 43 ITEM 6. EXHIBITS 44
SIGNATURES
SIGNATURES 2 Table of Contents
: FINANCIAL INFORMATION
PART I: FINANCIAL INFORMATION
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Select Medical Holdings Corporation Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share amounts) December 31, 2023 June 30, 2024 ASSETS Current Assets: Cash and cash equivalents $ 84,006 $ 111,160 Accounts receivable 940,335 1,077,984 Prepaid income taxes 22,726 8,448 Current portion of interest rate cap contract 58,962 22,426 Other current assets 151,617 145,069 Total Current Assets 1,257,646 1,365,087 Operating lease right-of-use assets 1,188,616 1,252,839 Property and equipment, net 1,023,561 1,030,587 Goodwill 3,513,170 3,525,474 Identifiable intangible assets, net 329,916 316,930 Other assets 376,722 384,385 Total Assets $ 7,689,631 $ 7,875,302 LIABILITIES AND EQUITY Current Liabilities: Overdrafts $ 30,274 $ 23,625 Current operating lease liabilities 245,400 247,920 Current portion of long-term debt and notes payable 70,329 46,431 Accounts payable 174,312 160,129 Accrued and other liabilities 728,150 778,894 Total Current Liabilities 1,248,465 1,256,999 Non-current operating lease liabilities 1,025,867 1,091,784 Long-term debt, net of current portion 3,587,675 3,593,660 Non-current deferred tax liability 143,306 97,647 Other non-current liabilities 110,303 98,682 Total Liabilities 6,115,616 6,138,772 Commitments and contingencies (Note 14) Redeemable non-controlling interests 26,297 29,565 Stockholders' Equity: Common stock, $ 0.001 par value, 700,000,000 shares authorized, 128,369,492 and 130,025,562 shares issued and outstanding at 2023 and 2024, respectively 128 130 Capital in excess of par 493,413 519,280 Retained earnings 751,856 891,397 Accumulated other comprehensive income 42,907 5,782 Total Stockholders' Equity 1,288,304 1,416,589 Non-controlling interests 259,414 290,376 Total Equity 1,547,718 1,706,965 Total Liabilities and Equity $ 7,689,631 $ 7,875,302 The accompanying notes are an integral part of these cond